// App-Quantinova.ai

PO0503 : Treatment Pathways of Patients with CKD: A Report from the DISCOVER CKD Retrospective Cohort

Researchers

Presenter

  • James Glen

Principal Investigators

  • Carrero JuanJesus

  • Kumar SupriyaR

  • Fishbane Steven

  • Moreno Quinn CarolPatricia

  • L Heerspink HiddoJan

  • Wittbrodt EricT

  • Kanda Eiichiro

  • Hedman Katarina

  • Kashihara Naoki

  • Chen Hungta (tony)

  • Kosiborod Mikhail

  • Carolyn LamSu ping

  • Pollock CarolA

  • Stenvinkel Peter

  • Pecoits-Filho Roberto

  • Wheeler DavidC

Medical Centers

  • AstraZeneca UK Ltd Cambridge Cambridgeshire United Kingdom

  • Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

  • AstraZeneca Gaithersburg Maryland United States

  • Northwell Health, Manhasset, New York, United States

  • University of Groningen, Groningen, Netherlands

  • Kawasaki Medical School Kurashiki Okayama Japan

  • AstraZeneca, Gothenburg, Sweden

  • Saint Luke's Hospital of Kansas City Health Sciences Library Kansas City Missouri United States

  • National Cancer Centre Singapore, Singapore, Singapore

  • University of Sydney, Sydney, New South Wales, Australia

  • Karolinska Universitetssjukhuset-Huddinge, Huddinge, Sweden

  • Pontificia Universidade Catolica do Parana (PUC-PR), Curitiba, Brazil

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

  • Sweden

  • United States

  • Netherlands

  • Japan

  • Singapore

  • Australia

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved